Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study

NCT05612594 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

164

Enrollment

OTHER

Sponsor class

Conditions

Sleep Apnea

Interventions

DRUG: Bexagliflozin 20 mg
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]